Abstract
Single nucleotide polymorphisms (SNP) in the CYBA gene encoding p22phox have been associated with respiratory burst and cardiovascular phenotypes. We previously reported a reduced phagocytic respiratory burst activity in healthy adults with the C242T SNP, but found no correlation between CYBA SNPs and coronary artery disease (CAD) phenotype. Using lymphoblastoid cells, we hypothesized that CYBA SNPs affect enzyme activity in patients with cardiovascular disease (CVD), but would not be associated with angiographic severity of CAD due to confounding by risk factors. We established lymphoblastoid cell lines from patients with CVD and genotyped the study cohort for CYBA SNPs and phenotyped each subjects coronary angiogram for CAD severity. As quantified by electron spin resonance, superoxide production in picomoles per 106 resting lymphoblastoid cells per minute for the CC, CT, and TT genotypes of the C242T SNP were 16.2±1.4, n=70, 11.9±0.7, n=87, and 11.9±1.5, n=28, respectively (P=0.002). The -930A/G and A640G SNPs did not affect superoxide production (P > 0.2). Expression of p22phox was not affected as determined by real-time RT-PCR and Western blot analysis. The C242T CYBA SNP is associated with altered NADPH oxidase activity in lymphoblastoid cells of patients with CVD. By reducing the influence of confounding environmental factors, lymphoblastoid cell lines could serve as a tool to assess direct genotype/phenotype interactions of candidate genes known to affect atherosclerosis.
Keywords: NADPH oxidase, CYBA, SNP, coronary heart disease, atherosclerosis, genetic association, genotype-phenotype relationship, functional genomics
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease
Volume: 7 Issue: 3
Author(s): P. Mehranpour, S. S. Wang, R. R. Blanco, W. Li, Q. Song, B. Lassegue, S. I. Dikalov, H. Austin and A. M. Zafari
Affiliation:
Keywords: NADPH oxidase, CYBA, SNP, coronary heart disease, atherosclerosis, genetic association, genotype-phenotype relationship, functional genomics
Abstract: Single nucleotide polymorphisms (SNP) in the CYBA gene encoding p22phox have been associated with respiratory burst and cardiovascular phenotypes. We previously reported a reduced phagocytic respiratory burst activity in healthy adults with the C242T SNP, but found no correlation between CYBA SNPs and coronary artery disease (CAD) phenotype. Using lymphoblastoid cells, we hypothesized that CYBA SNPs affect enzyme activity in patients with cardiovascular disease (CVD), but would not be associated with angiographic severity of CAD due to confounding by risk factors. We established lymphoblastoid cell lines from patients with CVD and genotyped the study cohort for CYBA SNPs and phenotyped each subjects coronary angiogram for CAD severity. As quantified by electron spin resonance, superoxide production in picomoles per 106 resting lymphoblastoid cells per minute for the CC, CT, and TT genotypes of the C242T SNP were 16.2±1.4, n=70, 11.9±0.7, n=87, and 11.9±1.5, n=28, respectively (P=0.002). The -930A/G and A640G SNPs did not affect superoxide production (P > 0.2). Expression of p22phox was not affected as determined by real-time RT-PCR and Western blot analysis. The C242T CYBA SNP is associated with altered NADPH oxidase activity in lymphoblastoid cells of patients with CVD. By reducing the influence of confounding environmental factors, lymphoblastoid cell lines could serve as a tool to assess direct genotype/phenotype interactions of candidate genes known to affect atherosclerosis.
Export Options
About this article
Cite this article as:
Mehranpour P., Wang S. S., Blanco R. R., Li W., Song Q., Lassegue B., Dikalov I. S., Austin H. and Zafari M. A., The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease, Cardiovascular & Hematological Agents in Medicinal Chemistry 2009; 7 (3) . https://dx.doi.org/10.2174/187152509789105417
DOI https://dx.doi.org/10.2174/187152509789105417 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Theoretical Possibilities for the Development of Novel Antiarrhythmic Drugs
Current Medicinal Chemistry Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews The Location of Vascular Flap is Related with Daily Activity Patterns in Non-traumatic Acute Aortic Syndrome in a Chinese Population
Current Signal Transduction Therapy Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants
Current Cardiology Reviews Effect of Non-antihypertensive Drugs on Endothelial Function in Hypertensive Subjects Evaluated by Flow-mediated Vasodilation
Current Vascular Pharmacology Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Current Vascular Pharmacology Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Calreticulin in the Heart: From Embryological Development to Cardiac Pathology.
Current Molecular Medicine Targeting Antibody-Mediated Rejection in the Setting of ABOIncompatible Infant Heart Transplantation: Graft Accommodation vs. B Cell Tolerance
Current Drug Targets - Cardiovascular & Hematological Disorders Pathophysiology of Diabetic Dyslipidaemia
Current Vascular Pharmacology Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-Analysis
Current Vascular Pharmacology The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews The Effect of Borage (Echium amoenum) on the Mouse Heart and Hematology Parameters
Cardiovascular & Hematological Disorders-Drug Targets Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Pitavastatin Combined with Ezetimibe Treatment was an Effective Approach to Non-IRA Lesion of ST-segment Elevation Myocardial Infarction Patients with Primary Percutaneous Coronary Intervention
Current Pharmaceutical Biotechnology